Medicure was founded in 1997 and became a public company in November 1999. The company trades under the symbol MPH on the TSX Venture Exchange. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharma companies in order to realize long term value.

2022 Second Quarter Results

We announced our second quarter 2022 results for the period which ended 30 June 2022 on Thursday, August 25.

Earnings Highlights | Earnings Presentation | Conference Call

Events, presentations, stock information,
reports and more to keep you informed


View our calendar of upcoming conferences, roadshows and other events, in addition to dates, locations, and further details.

Presentations/Conference Calls

Review our earnings calls, investor conferences, shareholder meetings, and more.

Stock Information

Medicure Inc. is publicly traded on the TSX Venture Exchange. Find an interactive share price chart for the Medicure Inc. (MPH) stock.

Quarterly Reports

Find quarterly financial information such as Statement of Income, Balance Sheet, and Statement of Cash flows.

Annual Reports

Find annual financial information such as Statement of Income, Statement of Financial Position, Statement of Cash Flows and Per share data.

Investors Contacts

For questions about investor relations, please contact our team.

Unite Interactive